AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Learn effective wealth strategies tailored for dual income households. Maximize your financial potential and achieve your goals.
18,063 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Peter Thiel warns that AI may imperil technical roles more than creative ones, a shift that could reshape wages and p...
BlackRock has launched a new staked Ethereum ETF, ETHB, blending spot ETH exposure with on-chain staking. Early data ...
NVIDIA leads AI chips while MICRON powers AI memory. This in-depth comparison helps investors decide the better buy: ...
Colgate-Palmolive posted stronger-than-expected Q1 2026 results, setting the stage for upside despite tariff headwind...
Two leading travel platforms, Booking Holdings and Airbnb, each chart different revenue paths. This article breaks do...
Bank of America climbs as a cross-border real-time payments plan expands. This development could steer the stock mark...
San Antonio is drawing a growing wave of military retirees, changing the city’s investment calculus as healthcare acc...
As deposit wars heat up in 2026, this report weighs the real value of chasing checking account bonuses worth the effo...
Suncor Energy has climbed sharply this year, but is the rally justified for new buyers? This guide breaks down the dr...
Scorpio Tankers has moved from a debt-laden balance sheet to net cash of roughly $334 million by early 2026, a develo...
Antero Midstream logged 271% total returns over three years and closed a $1.1 billion Marcellus asset deal. The 2026 ...